NCT03167697View on ClinicalTrials.gov

Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

September 20, 2018

Study Completion Date

December 17, 2018

Conditions
PhenylketonuriasHyperphenylalaninaemia, Type I
Interventions
DIETARY_SUPPLEMENT

Synergy

Small serving (x1 33 g serving daily) of the new phenylalanine-free protein substitute made up with 100mL of water daily (28 days).

OTHER

Routine

Patients will continue their usual dietary and/or protein substitute regimen (28 days).

Trial Locations (6)

Unknown

Queen Elizabeth Hospital, Birmingham

Royal Hospital for Sick Children, Edinburgh

Queen Elizabeth University Hospital, Glasgow

Guys & St Thomas' Hospital, London

Royal Victoria Infirmary, Newcastle upon Tyne

Southampton General Hospital, Southampton

All Listed Sponsors
lead

Nutricia UK Ltd

INDUSTRY

NCT03167697 - Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia | Biotech Hunter | Biotech Hunter